PCRX · Pacira BioSciences, Inc.
$23.00
-0.18 (-0.78%)
At close · Aug 14
Market Cap
$916.82M
Shares
39.86M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Remaining Authorization
$100,000,000
as of 2026-06-30
Program Utilization
66.7%
$200,000,000 used of $300,000,000
| Program Announced | Authorized | Remaining | As of | Runs Through | Source |
|---|---|---|---|---|---|
| 2025-04-17 | $300,000,000 | $100,000,000 | 2026-06-30 | 2026-12-31 | 10-Q , filed 2026-08-04 |
Cash spent on buybacks by quarter
Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2026-06-30 YTD | $50,045,000 | 10-Q, filed 2026-08-04 |
| 2025-12-31 | $148,328,000 | 10-K, filed 2026-02-26 |
| 2024-12-31 | $25,000,000 | 10-K, filed 2026-02-26 |
| 2023-12-31 | $0 | 10-K, filed 2026-02-26 |
| 2022-12-31 | $0 | 10-K, filed 2025-02-27 |
| 2010-12-31 | $2,000 | 10-K, filed 2013-03-07 |
Key facts
CIK
1396814
CUSIP
695127100
13F (30d)
234 filings
230 filers
Visit website
Investor relations